「蛍光生物学」の最前線 8-2

参考文献

1） S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel and A. W. Ferrante, “Obesity is associated with macrophage accumulation in adipose tissue”, J. Clin. Invest., 2003, 112（12）, 1796-1808.

2） G. S. Hotamisligil, “Inflammation and metabolic disoreders”, Nature, 2006, 444（7121）, 860-867.

3） S. Nishimura, I. Manabe, M. Nagasaki, Y. Hosoya, H. Yamashita, H. Fujita, M. Ohsugi, K. Tobe, T. Kadowaki, R. Nagai and S. Sugiura, “Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels”, Diabetes, 2007, 56, 1517-1526.

4） S. Nishimura, I. Manabe, M. Nagasaki, K. Seo, H. Yamashita, Y. Hosoya, M. Ohsugi, K. Tobe, T. Kadowaki, R. Nagai and S. Sugiura, “In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue”, J. Clin. Invest., 2008, 118（2）, 710-721.

5） S. Nishimura, I. Manabe, M. Nagasaki, K. Eto, H. Yamashita, M. Ohsugi, M. Otsu, K. Hara, K. Ueki, S. Sugiura, K. Yoshimura, T. Kadowaki and R. Nagai, “CD8⁺ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity”, Nature Medicine, 2009, 15:8, 914-920.

6） S. Winer, Y. Chan, G. Paltser, D. Truong, H. Tsui, J. Bahrami, R. Dorfman, Y. Wang, J. Zielenski, F. Mastronardi, Y. Maezawa, D. J. Drucker, E. Engleman, D. Winer and H. M. Dosch, “Normalization of obesity-associated insulin resistance through immunotherapy”, Nature Medicine, 2009, 15:8, 921-929.

7） J. Liu, A. Divoux, J. Sun, J. Zhang, K. Clement, J. N. Glickman, G. K. Sukhova, P. J. Wolters, J. Du, C. Z. Gorgun, A. Doria, P. Libby, R. S. Blumberg, B. B. Kahn, G. S. Hotamisligil and G. P. Shi, “Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice”, Nature Medicine, 2009, 15:8, 940-945.

8） M. Feuerer, L. Herrero, D. Cipolletta, A. Naaz, J. Wong, A. Nayer, J. Lee, A. B. Goldfine, C. Benoist, S. Shoelson and D. Mathis, “Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters”, Nature Medicine, 2009, 15:8, 930-939.

9） S. Nishimura, I. Manabe, M. Nagasaki, S. Kakuta, Y. Iwakura, N. Takayama, J. Ooehara, M. Otsu, A. Kamiya, B. Petrich, T. Urano, T. Kadono, S. Sato, A. Aiba, H. Yamashita, S. Sugiura, T. Kadowaki, H. Nakauchi, K. Eto and R. Nagai, “In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling”, Blood, 2012, 119, e15-e56.

10） S. Nishimura, H. Takizawa, N. Takayama, A. Oda, H. Nishikii, Y. Morita, S. Kakinuma, S. Yamazaki, S. Okamura, N. Tamura, S. Goto, A. Sawaguchi, I. Manabe, K. Takatsu, H. Nakauchi, S. Takaki and K. Eto, “Lnk/Sh2b3 regulates integrin alpha-IIb-beta3 outside-in signaling in platelets leading to stabilization of developing thrombus in vivo, ” J. Clin. Invest., 2010, 120（1）: 179-190.

11） S. T. Oh, E. F. Simonds, C. Jones, M. B. Hale, Y. Goltsev, K. D. Gibbs Jr., J. D. Merker, J. L. Zehnder, G. P. Nolan and J. Gotlib, “Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms”, Blood, 2010, 116（6）, 988-992.

12） T. L. Lasho, A. Pardanani and A. Tefferi, “LNK mutations in JAK2 mutation-negative erythrocytosis”, N. Engl. J. Med., 2010, 363（12）, 1189-1190.

13） N. Takayama, S. Nishimura, S. Nakamura, T. Shimizu, R. Ohnishi, H. Endo, T. Yamaguchi, M. Otsu, K. Nishimura, M. Nakanishi, A. Sawaguchi, R. Nagai, K. Takahashi, S. Yamanaka, H. Nakauchi and K. Eto, “Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells”, J. Exp. Med., 2010, 207（13）, 2817-2830